Sugar Editorial Picks
Oct 15, 2008 -
If staring at a computer screen all day has your eyes bugging out, try this simple trick for a little relief.
- Start by rubbing your palms together for about 10 seconds to build up heat in your hands.
- Place the heels of your hands lightly over your eyes and block out as much light as you can. Allow your finger tips to gently press into your forehead because chances are high it is tense, too.
- Hang out in the "dark" for five to 10 slow breaths.
- 6 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Complications
- Risk Factors
- Prevention
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccine News:
- On September 28, 2007, the U.S. Food and Drug Administration (FDA) approved a new brand of inactivated influenza ("flu") vaccine, Alfuria, for adults aged 18 years or older. This vaccine is given by injection.
- On September 19, 2007, the FDA approved the use of the live flu vaccine (FluMist) in healthy children as young as 2 years of age.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Prevention
- Treatment for Acute Sinusit...
- Treatment for Chronic Sinus...
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Restriction
In February 2007, the FDA announced that the antibiotic telithromycin (Ketek) should no longer be used for treatment of acute bacterial sinusitis. In June 2006, the FDA reported that several people had died of liver damage after taking this drug. Telithromycin is now only approved for treatment of community-acquired pneumonia.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Treatment
- Treatment for NSAID-Induced...
- Medications
- Treatment for Bleeding Ulce...
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Risk with cardiovascular medications
While nonsteroidal anti-inflammatory drugs are the major medications responsible for causing peptic ulcers, drugs taken for cardiovascular disease and its risk factors may also cause ulcers. Recent studies have found an association between increased risk of ulcer and the following drugs:
- Spironolactone, a common diuretic used in heart failure
- Niacin, a drug used to lower "bad" cholesterol and raise "good" cholesterol
- Vitamin K antagonists, commonly prescribed anticoagulants
- Dipyridamole, a drug for secondary stroke prevention
- Low-dose aspirin, prescribed for both heart attack and stroke prevention
Risk of peptic ulcer increases dramatically when these drugs are used in combination. Considering the millions of people who take these medications to prevent a life-threatening cardiovascular event, their impact on peptic ulcer development could be monumental.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Causes
- Risk Factors
- Diagnosis
- Managing Tension-Type Heada...
- Medications
- Treatment
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Global Prevalence of Tension-Type Headache
Tension-type headaches account for nearly half of all headaches, according to a 2007 study in Cephalagia. The researchers estimated that more people are disabled by tension-type headache than by migraine.
Causes of Tension-Type Headaches
Doctors are not really sure why tension-type headaches occur.
- 2 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Urinary Tract Infections (UTIs) in the United States
According to Urologic Diseases in America, a report published in 2007 by the U.S. National Institutes of Health:
- UTIs are the most expensive of all urologic diseases, accounting for about $3.5 billion a year in medical costs, including $96.4 million in prescriptions.
- Over 60% of women will experience a UTI at least once in their lifetime. At least a third of women experience a UTI by the time they are 24 years old.
- Only 20% of UTIs occur in men.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Causes
- Risk Factors
- Diagnosis
- Treatment Approaches
- Medications Used for Treatm...
- Prevention
- Medications Used for Preven...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Migraine Surveys
- About 17.1% of women and 5.6% of men suffer migraines, according to the 2007 American Migraine Prevalence and Prevention survey. Nearly a third of respondents reported 3 or more migraine attacks per month. Over half were severely impaired or needed bed rest during attacks.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Vaccination
- Diagnosis
- Treatment for Chickenpox...
- Treatment for an Acute Shin...
- Treatment for Postherpetic ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New Chickenpox Immunization Schedule
In 2007, the U.S. Centers for Disease Control (CDC) updated the immunization schedule for the chickenpox vaccine. The CDC now recommends that children receive two doses of the vaccine.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Biologic Drugs
- In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
- As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diphtheria, Tetanus, and Pe...
- Measles, Mumps, and Rubella...
- Varicella-Zoster Virus (Chi...
- Varicella-Zoster Virus (Shi...
- Hepatitis A
- Hepatitis B
- Pneumococcal Pneumonia
- Poliomyelitis
- Viral Influenza
- Haemophilus Influenzae Type...
- Human Papillomavirus (HPV)...
- Rotavirus
- Smallpox
- Other Vaccinations
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccines
- The Centers for Disease Control and Prevention now recommends that children receive 2 doses of the varicella-zoster (Chickenpox) vaccine: the initial vaccine between ages 12 - 15 months, and a booster between 4 - 6 years. Children aged 12 and older and adults who have not had the vaccine should receive 2 doses. Immunization guidelines were changed following research that indicated the effectiveness of the vaccine declines over time.
- 0 Comments